What's Going On With CVS Health Stock?
What's Going On With CVS Health Stock?
CVS Health Corp (NYSE:CVS) shares are trading marginally lower by 1.52% to $56.97 during Friday's session. The stock has been muted since the company earlier this week reported worse-than-expected second-quarter sales results and cut its FY24 adjusted EPS guidance below estimates.
CVS健康公司（NYSE：CVS）股票在周五的交易中轻微下跌1.52％至56.97美元。本周早些时候，该公司公布了二季度销售业绩低于预期并将其FY24调整后的每股收益指引下调至预期以下的业绩，从那以后股价一直很平静。
What Happened?
发生了什么？
CVS posted sales of $91.23 billion, slightly below the $91.51 billion consensus, with total revenues up 2.6%, driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments, though offset by a decline in the Health Services segment.
CVS的销售额为912.3亿美元，略低于915.1亿美元的共识，总收入增长2.6％，受到其医疗保健福利和药房及消费者健康业务增长的推动，虽然受到医疗服务业务下降的抵消。
Adjusted EPS was $1.83, down from $2.21 last year but above the $1.73 consensus. Operating income fell 16.4% to $3.74 billion. The Health Care Benefits segment's revenues grew by 21.4%, while the Health Services segment's revenues dropped by 8.8%.
调整后的每股收益为1.83美元，去年为2.21美元，但高于1.73美元的共识。营业收入下降16.4％至37.4亿美元。医疗保健福利业务收入增长了21.4％，而医疗服务业务收入下降了8.8％。
Leadership changes were announced, with CEO Karen Lynch taking direct control of the Health Care Benefits segment. CVS revised its 2024 adjusted EPS guidance to $6.40-$6.65, down from at least $7.00, and lowered its cash flow guidance due to continued pressure in the Health Care Benefits segment.
宣布了领导层变动，首席执行官Karen Lynch直接掌管医疗保健福利业务。CVS将其2024年调整后的每股收益指引修订为6.40-6.65美元，低于至少7.00美元，并由于医疗保健福利业务的持续压力而降低了其现金流指引。
Read Also: Boeing's New CEO Kelly Ortberg Shifts Base To Seattle Amid Airplane-Maker's Safety Crisis
读取也可以：波音新CEO凯利·奥特伯格在飞机制造商的安全危机中转移到西雅图总部
Is CVS A Good Stock To Buy?
CVS是一只值得购买的好股票吗？
Wall Street analysts view CVS Health on the whole as a Neutral, given the history of coverage over the past three months. Lisa Gill from JP Morgan in CVS Health is the most bearish, expecting a 14.85% fall in the stock in the coming year.
华尔街分析师普遍认为CVS Health是中立的，因为过去三个月的覆盖历史。摩根大通的Lisa Gill是CVS Health中最看淡的，预计该股在未来一年将下跌14.85％。
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, CVS Health rose 2.65%, which indicates that opinion improved on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 2.6% over the past year.
但是，观察整个市场对该股票的看法，您可以参考历史价格走势，以了解投资者对该股票持有的任何强烈观点。在过去的3个月中，CVS健康公司上涨了2.65％，这表明基于其股价或营业收入等基本面，市场对其业务及可持续性的看法有所改善。
A complete overview of how Wall Street views individual stocks is available here, while real time updates on the latest analyst actions will be delivered via Benzinga PRO. Try it for free.
可以在此处获得有关华尔街如何看待个股的完整概述，而最新分析师行动的实时更新将通过Benzinga PRO提供。立即免费试用。
CVS has a 52-week high of $83.25 and a 52-week low of $52.77.
CVS的52周高点为83.25美元，52周低点为52.77美元。